Current approaches in glioblastoma multiforme immunotherapy
Article in Clinical and Translational Oncology (March 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
Article in Frontiers in Immunology (February 2024)
Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
Article in Neuro-Oncology (November 2023)